Ehsanollah Esfandiari

Company: Kyowa Kirin

Job title: Global Head, Immunology R&D

Seminars:

Roundtable Discussion: Anti-Ox40 Therapeutic Landscape and Exploration of OX40 Targeting Industry Impact 12:00 pm

Join an interactive discussion exploring OX40 as an emerging therapeutic target in dermatology. Following a brief overview of mechanism and current pipeline landscape, experts will engage in an open forum discussion addressing key questions and industry impacts.  Where does OX40 targeting fit within current treatment paradigms, and what unique advantages might it offer over existing…Read more

day: Day One